Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Zynerba Pharma CS (ZYNE)

Zynerba Pharma CS (ZYNE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Regulators Move to Remove Restriction on Some Uses of Psilocybin

, /PRNewswire/ -- The political push for the legalization of psychedelic products is now underway. Earlier this week, an ballot measure to legalize the use of psilocybin, a naturally occurring psychedelic...

APHA : 4.30 (+2.63%)
ZYNE : 3.73 (+8.43%)
MYCOF : 0.6146 (-0.87%)
MYCO.CN : 0.870 (+2.35%)
NVS : 87.01 (-0.38%)
PFE : 33.83 (+1.11%)
APHA.TO : 5.83 (+2.64%)
Zynerba's Zygel Fails in Phase III Fragile X Syndrome Study

Zynerba's (ZYNE) shares plunge 48.5% following the study data readout, which demonstrated failure to achieve statistical significance in primary endpoint.

ALDX : 4.82 (-7.31%)
GWPH : 127.90 (-0.16%)
ZYNE : 3.73 (+8.43%)
ATXI : 9.76 (+0.10%)
Thinking about buying stock in YRC Worldwide, Zynerba Pharmaceuticals, Workhorse Group, Vaxart Inc, or United Airlines?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for YRCW, ZYNE, WKHS, VXRT, and UAL.

WKHS : 15.18 (-5.48%)
ZYNE : 3.73 (+8.43%)
Thinking about buying stock in Zomedica Pharmaceuticals, Nio Inc, Advanced Micro Devices, Norwegian Cruise Line, or Zynerba Pharmaceuticals?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ZOM, NIO, AMD, NCLH, and ZYNE.

AMD : 55.88 (-2.40%)
NCLH : 16.40 (+7.89%)
NIO : 14.98 (+2.81%)
ZYNE : 3.73 (+8.43%)
Zynerba Pharmaceuticals Announces Top Line Results from Pivotal CONNECT-FX Trial of Zygel(TM) (CBD Gel) in Fragile X Syndrome

- Study Did Not Achieve Statistical Significance in Primary or Key Secondary Endpoints in Full Analysis Set -

ZYNE : 3.73 (+8.43%)
Implied Volatility Surging For Zynerba Pharmaceuticals (ZYNE) Stock Options

Investors need to pay close attention to Zynerba Pharmaceuticals (ZYNE) stock based on the movements in the options market lately.

ZYNE : 3.73 (+8.43%)
Zacks Market Edge Highlights: Canopy Growth, Aurora Cannabis, Hexo, GW Pharmaceuticals and Zynerba

Zacks Market Edge Highlights: Canopy Growth, Aurora Cannabis, Hexo, GW Pharmaceuticals and Zynerba

GWPH : 127.90 (-0.16%)
ZYNE : 3.73 (+8.43%)
CGC : 17.42 (+8.74%)
ACB : 12.02 (+2.12%)
HEXO : 0.7500 (+1.99%)
Is This a Buying Opportunity in the Marijuana Stocks?

The marijuana stocks plunged during the coronavirus sell-off. Should investors be taking a second look?

GWPH : 127.90 (-0.16%)
ZYNE : 3.73 (+8.43%)
CGC : 17.42 (+8.74%)
ACB : 12.02 (+2.12%)
HEXO : 0.7500 (+1.99%)
Therapeutic Use of CBD Continues to Spread

, /PRNewswire/ -- There has been a substantial growth in demand for cannabidiol (CBD) products around the globe in recent years, mainly in developed countries such as the U.S., , and the Netherlands. As...

SRNE : 8.06 (+4.00%)
VFF : 5.10 (+2.62%)
WBA : 40.12 (+2.85%)
TAAT.CN : 0.830 (-5.68%)
ZYNE : 3.73 (+8.43%)
VFF.TO : 6.91 (+3.13%)
Psychedelics Represent a New Frontier for Mental Healthcare

, /PRNewswire/ -- Despite the various stigmas associated with psychedelics, there is a growing acceptance of using psychedelic drugs specifically to treat depression. Such drugs have regularly proven...

IIPR : 90.78 (+1.15%)
NLBIF : 0.6150 (-6.82%)
MYCO.CN : 0.870 (+2.35%)
ZYNE : 3.73 (+8.43%)
APHA : 4.30 (+2.63%)
CGC : 17.42 (+8.74%)
WEED.TO : 23.66 (+8.14%)
Studies Into Psychedelic Drugs Reveal Significant Medical Potential

, /PRNewswire/ -- Psychedelic drugs include a range of substances with varying pharmacological profiles that all have strong effects on the consumer's conscious experience. Such products are borne from...

AMRS : 4.43 (+1.61%)
VFF : 5.10 (+2.62%)
ZYNE : 3.73 (+8.43%)
NUMI.VN : 0.320 (+3.23%)
LKYSD : 0.3330 (+17.54%)
VFF.TO : 6.91 (+3.13%)
NEPT.TO : 4.26 (-3.18%)
Implied Volatility Surging for Zynerba Pharmaceuticals (ZYNE) Stock Options

Investors need to pay close attention to Zynerba Pharmaceuticals (ZYNE) stock based on the movements in the options market lately.

ZYNE : 3.73 (+8.43%)
Zynerba Pharmaceuticals Announces New Two-Year Data from Open Label Extension of the Phase 2 FAB-C Trial in Patients with Fragile X at 2020 American Academy of Neurology (AAN) Science Highlights Virtual Session

- Robust Response Sustained through Two Years of Treatment with Zygel(TM) in Patients from Phase 2 FAB-C Trial -

ZYNE : 3.73 (+8.43%)
Zynerba Pharmaceuticals Announces Presentation of Phase 2 BELIEVE Safety, Efficacy and Quality of Life Data in Developmental and Epileptic Encephalopathies (DEE) at the 2020 American Academy of Neurology (AAN) Science Highlights Virtual Session

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, is presenting two posters...

ZYNE : 3.73 (+8.43%)
Stocks Surge More Than 3% This Week

Stocks Surge More Than 3% This Week

HEXO : 0.7500 (+1.99%)
ZYNE : 3.73 (+8.43%)
KERN : 7.51 (+3.30%)
SPLK : 211.32 (+3.16%)
PANW : 248.96 (+0.15%)
BABA : 261.01 (-0.22%)
MRNA : 62.61 (-3.63%)
Is Zynerba Pharmaceuticals (ZYNE) Stock Outpacing Its Medical Peers This Year?

Is (ZYNE) Outperforming Other Medical Stocks This Year?

ZYNE : 3.73 (+8.43%)
Zynerba Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced that...

ZYNE : 3.73 (+8.43%)
Researchers Delve Into Psychedelics in Search of Novel Therapies

, /PRNewswire/ -- The trend of cannabis legalization in several countries is one of the key factors driving the market's growth. Additionally, the use of cannabis for medical purposes is gaining momentum...

ZYNE : 3.73 (+8.43%)
NLBIF : 0.6150 (-6.82%)
NLB.CN : 1.000 (+12.36%)
CRON : 6.32 (+4.98%)
XXII : 0.7558 (-2.57%)
Zynerba Pharmaceuticals Changes Annual Meeting of Shareholders to Virtual-Only Format in Response to COVID-19 Pandemic

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced that...

ZYNE : 3.73 (+8.43%)
Dow, S&P Jump Over 3% on Encouraging Vaccine Data

Dow, S&P Jump Over 3% on Encouraging Vaccine Data

CVX : 85.23 (+3.01%)
COG : 17.60 (+3.35%)
SIMO : 43.76 (-0.09%)
GSKY : 5.10 (+3.24%)
AINV : 9.20 (+1.88%)
NVDA : 419.17 (-0.28%)
SDOW : 23.06 (-4.24%)
SPXS : 7.13 (-2.99%)
PLT : 14.76 (-4.03%)
NOMD : 21.13 (+1.44%)
CNX : 8.43 (-0.94%)
FLO : 21.97 (+1.29%)
HUM : 381.58 (-0.35%)
HEXO : 0.7500 (+1.99%)
ZYNE : 3.73 (+8.43%)
CCL : 16.16 (+10.84%)
UAL : 32.67 (+8.29%)
DAL : 27.09 (+5.61%)
LUV : 33.22 (+5.23%)
C : 52.65 (+6.47%)
WFC : 25.47 (+5.95%)
BAC : 24.02 (+5.49%)
JPM : 96.27 (+5.47%)
MRNA : 62.61 (-3.63%)
WMT : 130.68 (+2.29%)
HD : 250.11 (+0.87%)

Van Meerten Stock Picks

My 5 Favorite Mid Caps
Summary 100% technical buy signals with current momentum.
CRUS +0.29 , SEDG +2.26 , THC +0.97 , TER -1.08 , LITE -1.41
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar